Futura Increases Market Share for High-End Tissue Converting Solutions

Futura has had a record 12 months, increasing its market share for high-end tissue converting solutions worldwide. Futura’s breakthrough Andromeda technology was delivered to Europe and the United States while additional lines were started up for key clients in Europe, South America and Mexico.

The same period also saw orders received and prospects developed from the Chinese market for Futura solutions.

"Thanks to its people, passion, values and strong customer relationships, Futura has been able to set new benchmarks in integrated performance and significantly consolidate its technological leadership," said vice president of international operations, Piero Ceccon. "Futura is well-prepared for its next growth phase, with significant investments already committed for 2017. These include important developments in R&D at FuturaLab in Lucca, and in global service both at the manufacturing headquarters in Lucca and the North America hub of operations in Alpharetta, Georgia."